Rechallenge After Oxaliplatin-Induced Hypersensitivity Reactions

JAMA Oncol. 2023 Mar 1;9(3):434-435. doi: 10.1001/jamaoncol.2022.7136.
No abstract available

Plain language summary

This cohort study assesses the outcome of oxaliplatin desensitization for patients with gastrointestinal cancers who experienced hypersensitivity reactions after oxaliplatin infusion.

Publication types

  • Letter

MeSH terms

  • Antineoplastic Agents* / adverse effects
  • Colorectal Neoplasms* / drug therapy
  • Humans
  • Oxaliplatin / adverse effects

Substances

  • Oxaliplatin
  • Antineoplastic Agents